• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH); IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH); IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/06/2023
Event Type  malfunction  
Event Description
A customer reports observation of discordant elevated atellica im high-sensitivity troponin i (tnih) results for one patient sample which were discordant relative to alternate-method testing.An initial elevated atellica im tnih result was obtained.Per customer protocol, the same sample was re-tested in duplicate on the atellica im analyzer; similarly-elevated tnih results were obtained.The sample was also tested using an alternate-method test, which produced a much lower result.There are no allegations of patient harm, changes in treatment, or delays of diagnosis or treatment resulting from the observed result discordance.The customer has reported this observation of discordance retrospectively.Customers in australia are required to report discordant results to their competent authority (tga) and notify the manufacturer; this may be done retrospectively in a summary manner.The customer has declined to provide any additional information regarding patient diagnosis or treatment, and ultimate determinations regarding result indications.The customer also declined to provide any complaint materials and patient samples for siemens investigation.
 
Manufacturer Narrative
This incident occurred outside the united states.The customer has reported these observations of disagreement between methods retrospectively and not in a timely manner.The observations have been reported to siemens to comply with australian regulations (tga).Customers in australia are required to report discordant results to their competent authority (tga) and notify the manufacturer and this may be done retrospectively in a summary manner.The assay¿s instructions for use (ifu) states the following, under interpretation of results: ¿results of this assay should always be interpreted in conjunction with the patient¿s medical history, clinical presentation, and other findings.¿ it is noted that atellica im tnih is a high-sensitivity troponin i method whereas the alternate method is a point-of-care conventional-sensitivity troponin i method.Results from different methods are not interchangeable due to differences in assay specificity and sensitivity.The following is stated in the ifu, under limitations: ¿values obtained with different assay methods cannot be used interchangeably.Interpretations using serial measurements should be based on results obtained with the same assay method.The measured concentration of ctni in a given specimen can vary between assays due to differences in assay design and methodology.¿ there is no expectation that atellica im tnih and alternate troponin test methods will produce similar results.The customer has declined to provide any additional information regarding patient diagnosis or treatment, and ultimate determinations regarding result indications.The customer also declined to provide any complaint materials and patient samples for siemens investigation.Therefore, siemens is unable to further investigate this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH)
Type of Device
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
east walpole MA 02032
Manufacturer Contact
barry memishian
333 coney st.
east walpole, MA 02032
5082985306
MDR Report Key18803015
MDR Text Key337623117
Report Number1219913-2024-00048
Device Sequence Number1
Product Code MMI
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K171566
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number10997841
Device Lot Number090
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/23/2024
Date Device Manufactured02/20/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-